All Posts: News Release
-
Computer Models Fill Critical Knowledge Gaps To Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to a new, wide-ranging perspective by researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues. A collection of new studies in the November 8, 2023, special issue of JNCI devoted to cancer disparities modeling outlines a path forward.
Category: News Release
-
Tobacco Regulations Center Receives $20 Million for Tobacco Use Research
The Center for the Assessment of Tobacco Regulations (CAsToR) — a collaboration with Georgetown University, the University of Michigan, and the British Columbia (BC) Cancer Research Institute — recently received $20 million in funding to continue its research on the impact of tobacco regulations on tobacco use patterns and their downstream health effects.
Category: News Release
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release
-
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging. Using novel epigenetic measures to assess biological aging, investigators found that older breast cancer survivors — particularly those exposed to chemotherapy — showed greater epigenetic aging than their same-aged peers without cancer, which may relate to worse outcomes.
Category: News Release
-
Determining How a Sugar Molecule Can Affect Cancer Cell Response to Chemoradiotherapy
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules. When this pathway is overactive, it can lead to cancer and resistance to chemoradiotherapy.
Category: News Release
-
Veterans Exposed to Agent Orange May Be at Increased Risk of Developing Progressive Blood Cancers
Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins.
Category: News Release
-
Types of Bacteria Vary Widely in Tumors of People with Early vs. Late-Onset Colorectal Cancer
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the makeup of the bacteria, fungi and viruses in a person’s tumor varied significantly depending on whether they were diagnosed with early onset disease (age 45 or younger) or late-onset disease (age 65 or older).
Category: News Release
-
Georgetown Announces New Ralph Lauren Center for Cancer Prevention To Address Health Disparities in Washington, D.C.
Media Contact Karen Teberkm463@georgetown.edu WASHINGTON (April 10, 2023) — The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center will open on Mond
Category: News Release
-
$3.2 Million Grant Supports Study of New Genetic Testing Approach to Reduce Racial Health Disparities
The National Cancer Institute has awarded a $3.2 million grant to investigators from Georgetown University’s Lombardi Comprehensive Cancer Center and Rutgers Cancer Institute of New Jersey, both NCI-designated Comprehensive Cancer Centers, to examine a novel approach to genetic testing and care based on community-identified needs, with the aim of reducing racial disparity gaps in cancer care delivery.
Category: News Release